What is the recommended acute management for a patient with suspected myocardial infarction?

Acute Management of Suspected Myocardial Infarction

For suspected myocardial infarction, immediately obtain a 12-lead ECG within 10 minutes of first medical contact, administer aspirin (oral or IV), initiate ECG monitoring with defibrillator capacity, and pursue urgent reperfusion therapy—primary PCI is the preferred strategy if achievable promptly, otherwise administer fibrinolytic therapy within 12 hours of symptom onset if PCI will be delayed. 1

Initial Assessment and Stabilization

Immediate Actions (Within 10 Minutes)

• 12-lead ECG: Obtain and interpret within 10 minutes of first medical contact to determine if ST-segment elevation is present 1
• ECG monitoring: Initiate continuous monitoring with defibrillator capacity immediately 1
• Aspirin: Administer 75-100 mg oral aspirin (or IV if unable to swallow) as soon as possible unless contraindicated 1
• Oxygen: Only administer if SaO2 <90%—routine oxygen is NOT recommended 1

Critical pitfall: Do not delay reperfusion therapy while waiting for cardiac biomarkers. The diagnosis of STEMI is based on clinical presentation and ECG findings, not troponin levels 1.

Reperfusion Strategy Selection

Primary PCI (Preferred Method)

Primary PCI is superior to fibrinolysis and should be performed as the default reperfusion strategy 1. The key is timing:

• Direct catheterization lab transfer: Bypass the emergency department and CCU—go directly to the cath lab 1
• 24/7 availability: PCI-capable centers must provide round-the-clock service 1
• Reperfusion therapy is indicated for all patients with symptoms <12 hours duration and persistent ST-elevation 1

Fibrinolytic Therapy (When PCI Delayed)

If primary PCI cannot be performed in a timely manner, administer fibrinolytic therapy within 12 hours of symptom onset 1. Initiate preferably in the pre-hospital setting 1.

Fibrin-specific agents to use 1:

• Tenecteplase
• Alteplase
• Reteplase

Mandatory adjunctive therapy with fibrinolysis 1:

• Aspirin (oral or IV)
• Clopidogrel in addition to aspirin
• Anticoagulation: Enoxaparin IV followed by subcutaneous (preferred over unfractionated heparin) OR weight-adjusted UFH bolus with infusion

Post-fibrinolysis management 1:

• Transfer ALL patients to PCI-capable center immediately after fibrinolysis
• Perform angiography and PCI of infarct-related artery between 2-24 hours after successful fibrinolysis
• Rescue PCI immediately if fibrinolysis fails (<50% ST-segment resolution at 60-90 minutes) or if hemodynamic/electrical instability develops

Antiplatelet and Anticoagulation Therapy

For Primary PCI Patients

Dual antiplatelet therapy 1:

• Aspirin (as above)
• Plus a potent P2Y12 inhibitor: Prasugrel or ticagrelor preferred (use clopidogrel only if these are unavailable or contraindicated)
• Administer before or at latest at the time of PCI
• Continue for 12 months unless excessive bleeding risk

Anticoagulation 1:

• Do NOT use fondaparinux for primary PCI 1
• Use unfractionated heparin or bivalirudin instead

For Fibrinolysis Patients

As detailed above: aspirin + clopidogrel + enoxaparin (preferred) or UFH 1

Special Circumstances

Cardiac Arrest with STEMI

• Primary PCI is the recommended reperfusion strategy 1
• Initiate targeted temperature management early in patients who remain unresponsive 1
• Avoid rapid infusion of large volumes of cold IV fluid for pre-hospital cooling 1

Heart Failure or Cardiogenic Shock

• Emergency angiography and PCI immediately 1

Asymptomatic Patients >48 Hours

• Do NOT perform routine PCI of occluded infarct-related artery >48 hours after STEMI onset 1

Additional Acute Management

Symptom Relief

• Nitroglycerin and morphine for chest pain relief 2
• Avoid routine oxygen unless hypoxemic 1

Beta-Blockers

Critical caveat: Avoid IV beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 1. Oral beta-blockers are indicated for patients with heart failure and/or LVEF <40% 1.

Early Medical Therapy (Within 24 Hours)

• High-intensity statin therapy: Start as early as possible 1
• ACE inhibitors: Start within first 24 hours in patients with heart failure, LV dysfunction, diabetes, or anterior infarct 1
• PPI: For patients at high GI bleeding risk on dual antiplatelet therapy 1

Risk Stratification

Routine echocardiography during hospital stay is recommended in all patients to assess LV/RV function, detect mechanical complications, and exclude LV thrombus 1.